Overlapping and independent functions of fibronectin receptor integrins in early mesodermal development.
Mouse embryos deficient in fibronectin (FN-null) die at E8.5 with mesodermal defects. Eight integrin heterodimers alpha3beta1, alpha4beta1, alpha5beta1, alpha8beta1, alphavbeta1, alphavbeta3, alphavbeta6, and alphaIIbbeta3 can bind to FN. However, embryos deficient in each of these integrins exhibit less severe defects than do FN-null embryos, raising questions as to which integrin(s) are the key FN receptors for these early FN-dependent processes. alpha5beta1 is believed to be the key receptor and alpha5-null embryos display mesodermal defects similar to, although less severe than, those of FN-null. Here we report that the alpha5-null mutation exhibits a more severe phenotype on a 129Sv (129) than on a C57BL/6 (B6) background, as does the FN-null mutation. While alpha5-null/B6 embryos develop normal headfolds, alpha5-null/129 embryos have headfold defects similar to those of FN-null. The differences between FN-null and alpha5-null embryos, however, cannot be attributed to genetic background. FN-null embryos never form somites, whereas in alpha5-null/129 embryos the somites do condense but fail to epithelialize. Second, we examined double mutants carrying all possible pairwise combinations of null mutations in alpha3, alpha4, and alpha5 integrin genes. There was no evidence for any synergy between paired mutations, suggesting that these integrin genes do not have overlapping functions during early embryonic development. Finally, we examined double-mutant embryos deficient in both alpha5 and alphav integrin genes. These double-mutant embryos have an amniotic defect similar to that of FN-null embryos, but die even earlier with a defect in gastrulation. These studies thus revealed a gradation in the severity of defects in the mutations alpha5(-/-); alphav(-/-) > FN(-/-) (129) > FN(-/-) (B6) > alpha5(-/-) (129) > alpha5(-/-) (B6), and in each step in this series there is a certain degree of phenotypic overlap, suggesting that the defects arising from these mutations may result from disruptions of the same embryonic process.
Yang
J T
JT
Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Bader
B L
BL
Kreidberg
J A
JA
Ullman-Culleré
M
M
Trevithick
J E
JE
Hynes
R O
RO
D000818:Animals; D015703:Antigens, CD / Q000502:physiology; D005260:Female; D005353:Fibronectins / Q000032:analysis; D039422:Integrin alpha3; D039441:Integrin alpha4; D039482:Integrin alpha5; D016023:Integrins / Q000502:physiology*; D008648:Mesoderm / Q000502:physiology*; D051379:Mice; D010641:Phenotype; D011247:Pregnancy; D017469:Receptors, Fibronectin / Q000502:physiology*
D015703:Antigens, CD; D005353:Fibronectins; D039422:Integrin alpha3; D039482:Integrin alpha5; D016023:Integrins; D017469:Receptors, Fibronectin; D039441:Integrin alpha4